1. Home
  2. IMNM vs GIS Comparison

IMNM vs GIS Comparison

Compare IMNM & GIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • GIS
  • Stock Information
  • Founded
  • IMNM 2006
  • GIS 1866
  • Country
  • IMNM United States
  • GIS United States
  • Employees
  • IMNM N/A
  • GIS N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • GIS Packaged Foods
  • Sector
  • IMNM Health Care
  • GIS Consumer Staples
  • Exchange
  • IMNM Nasdaq
  • GIS Nasdaq
  • Market Cap
  • IMNM 1.2B
  • GIS 28.0B
  • IPO Year
  • IMNM 2020
  • GIS N/A
  • Fundamental
  • Price
  • IMNM $16.18
  • GIS $48.84
  • Analyst Decision
  • IMNM Strong Buy
  • GIS Hold
  • Analyst Count
  • IMNM 9
  • GIS 15
  • Target Price
  • IMNM $24.89
  • GIS $56.93
  • AVG Volume (30 Days)
  • IMNM 1.8M
  • GIS 5.4M
  • Earning Date
  • IMNM 11-12-2025
  • GIS 09-17-2025
  • Dividend Yield
  • IMNM N/A
  • GIS 5.04%
  • EPS Growth
  • IMNM N/A
  • GIS 25.49
  • EPS
  • IMNM N/A
  • GIS 5.27
  • Revenue
  • IMNM $12,589,000.00
  • GIS $19,156,000,000.00
  • Revenue This Year
  • IMNM N/A
  • GIS N/A
  • Revenue Next Year
  • IMNM $140.06
  • GIS N/A
  • P/E Ratio
  • IMNM N/A
  • GIS $9.18
  • Revenue Growth
  • IMNM 16.74
  • GIS N/A
  • 52 Week Low
  • IMNM $5.15
  • GIS $47.48
  • 52 Week High
  • IMNM $17.08
  • GIS $71.00
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 70.52
  • GIS 46.04
  • Support Level
  • IMNM $15.11
  • GIS $47.48
  • Resistance Level
  • IMNM $17.08
  • GIS $48.66
  • Average True Range (ATR)
  • IMNM 1.14
  • GIS 0.96
  • MACD
  • IMNM 0.27
  • GIS -0.17
  • Stochastic Oscillator
  • IMNM 84.61
  • GIS 35.98

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About GIS General Mills Inc.

General Mills is a global packaged food company that produces snacks, cereal, convenient meals, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Pillsbury, Betty Crocker, Blue Buffalo, and Haagen-Dazs. In fiscal 2025, 81% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. Although most of General Mills' products are sold through retail stores to consumers, the company also sells products to the foodservice channel and the commercial baking industry.

Share on Social Networks: